Use of genetically modified bacteria for drug delivery in humans: Revisiting the safety aspect
Abstract The use of live, genetically modified bacteria as delivery vehicles for biologics is of considerable interest scientifically and has attracted significant commercial investment. We have pioneered the use of the commensal gut bacterium Bacteroides ovatus for the oral delivery of therapeutics...
Guardado en:
Autores principales: | Udo Wegmann, Ana Lucia Carvalho, Martin Stocks, Simon R. Carding |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d47528c7b1b741b89f5e48981a26bc68 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SOME ASPECTS OF EFFECTIVENESS AND SAFETY OF ANTIBACTERIAL DRUGS IN PREGNANCY
por: D. Y. Zhukova, et al.
Publicado: (2012) -
Genetically engineered nanocarriers for drug delivery
por: Shi P, et al.
Publicado: (2014) -
Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery
por: Zariwala MG, et al.
Publicado: (2018) -
Impact of endofungal bacteria on infection biology, food safety, and drug development.
por: Gerald Lackner, et al.
Publicado: (2011) -
Revisiting the genetic ancestry of Brazilians using autosomal AIM-Indels.
por: Fernanda Saloum de Neves Manta, et al.
Publicado: (2013)